Home › Aortic Arch Aneurysm › NCT07166133
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements. 2. Patient has been or is intended to be treated with the TBE Device in Zone 0 or Zone 1. 3. Patient is age ≥ 18 years at time of informed consent signature. Exclusion Criteria: 1. Patient who is, at the time of consent, unlikely to be available for defined follow-up visits. 2. Patient with exclusion criteria required by local law. 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or investigational device study within 12 months of study enrollment. Subjects cannot be enrolled in another Gore study.
About the study
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
What is being tested
- GORE® TAG® Thoracic Branch Endoprosthesis (device)
Sponsor: W.L.Gore & Associates · Participants: 125 · Started: Mar 2, 2026
Contact the study team
- DeAnne Hart · Phone: 800-437-8181
Official record on ClinicalTrials.gov — NCT07166133
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.